ORBIMED CAPITAL LLC 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:15 pm Sale |
2021-12-31 | 13G | Aptose Biosciences Inc. APTO |
ORBIMED CAPITAL LLC | 0 0.000% |
-17,844 (Position Closed) |
Filing |
| 2021-02-12 4:42 pm Purchase |
2020-12-31 | 13G | Aptose Biosciences Inc. APTO |
ORBIMED CAPITAL LLC | 17,844 9.040% |
17,844 (New Position) |
Filing |